A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

Autoria(s): Cook, G.; Clark, R.E.; Morris, T; Robertson, M.; Lucie, N.P.; Anderson, S.; Paul, J.; Franklin, I.M.
Data(s)

01/09/2004
Identificador

http://pure.qub.ac.uk/portal/en/publications/a-randomized-study-wos-mm1-comparing-the-oral-regime-zdex-idarubicin-and-dexamethasone-with-vincristine-adriamycin-and-dexamethasone-as-induction-therapy-for-newly-diagnosed-patients-with-multiple-myeloma(8980857f-860a-4afe-9e99-5f5348bde0c9).html

http://dx.doi.org/10.1111/j.1365-2141.2004.05127.x

http://www.scopus.com/inward/record.url?scp=4644305478&partnerID=8YFLogxK
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Cook , G , Clark , R E , Morris , T , Robertson , M , Lucie , N P , Anderson , S , Paul , J & Franklin , I M 2004 , ' A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma. ' British Journal of Haematology , vol 126(6) , no. 6 , pp. 792-798 . DOI: 10.1111/j.1365-2141.2004.05127.x
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2720 #Hematology
Tipo

article
Acesso ao item digital